Existing users please login

 
Untitled Document
Q&A With the Founder of Tremont Electric

Hate that feeling when you are on a run and look down to see your iPod is about to die? Or when you are on a hike, and your cell phone battery is about to run out of power?

Aaron LeMieux, founder of Tremont Electric, created nPower--a device that harnesses kinetic energy to power gadgets. LEARN MORE

Y Combinator

Y Combinator is a venture firm that specializes in moving companies from the idea stage into reality. It invests mostly in software and Web services companies, and says it looks for groups with technical depth and quality ideas. LEARN MORE

WATCH: Y Combinator: Funding Tech Start-ups

Fighting Antibiotic Resistance

This start-up, which focuses on bringing solar and wind technology to urbanites, is focused on finding funding to take its first product, Solar Ivy, to market. Still in its prototype phase, this decorative "ivy" may someday be able to power your business or house unobtrusively.
READ FULL STORY

SEE: Photo Gallery

WATCH: Solar Ivy

READ: Young Guns: A Plan to Generate Urban Power

Fighting Antibiotic Resistance

Michael Koeris and Tim Lu of Novophage Therapeutics on how their start-up biotech is trying to battle one of the biggest health-care problems facing America.

WATCH FULL INTERVIEW

Radical Computing Corporation

With the technology being developed by Radical Computing Corporation, you can stop playing the transportation guessing game and no need to waste your time trying to find an employee for help. RPNSignage creates intelligent devices that companies can program to target customers needs, provide information, and even load trivia games for bored patrons waiting in line.
READ FULL STORY

READ: Q&A With the President of Radical Computing Corporation

WATCH: Smart Signs: Changing How You Shop

Genocea Biosciences: Q and A with CEO Staph Bakali

Founded in 2006 with the brainpower of Harvard Medical School and the University of California at Berkeley, in February of this year, this startup company secured $23 million in venture capital funding to do what it does best: vaccines.

With a new technology that can mimic the human immune system in a lab, Genocea has opened the door for speedy vaccine development and the ability to test combinations of vaccines simultaneously. READ FULL Q & A

READ: Genocea's Timeline: The Path to Startup

WATCH: Biotech Start-up Success

InterShelter, Inc.


Untitled Document

LIVE Saturdays 10:00 a.m. - 2:00 p.m. ET

We believe in the American Dream and are here to help you make that dream come true: Starting, owning, running and growing your own business.

We're bringing you the best and brightest business owners, entrepreneurs and venture capitalists to answer all your questions to make your business a shining success. We're here for insight and inspiration.

Email your idea to us:
YourMoney@FOXBusiness.com